DAKO S0809抗體稀釋液antibody diluent

Intended use
For In Vitro Diagnostic Use. 
This product is intended for the preparation of primary and secondary antibody dilutions and negative control reagents for use in 
immunohistochemical (IHC) staining procedures. In the demonstration of tissue antigens by IHC, optimal staining performance usually 
requires the use of diluted antibodies (1). 
Refer to Dako’s General Instructions for Immunohistochemical Staining or the detection system instructions of IHC procedures for: 
1) Principle of Procedure, 2) Materials Required, Not Supplied, 3) Storage, 4) Specimen Preparation, 5) Staining Procedure, 6) Quality 
Control, 7) Troubleshooting, 8) Interpretation of Staining, 9) General Limitations. 

DAKO S0809抗體稀釋液antibody diluent

Reagent provided 
Tris-HCI buffer containing stabilizing protein and 0.015 mol/L sodium azide. 
Precautions 
1. For professional users. 
2. This product contains sodium azide (NaN3), a chemical highly toxic in pure form. At product concentrations, though not classified as 
hazardous, build-ups of NaN3 may react with lead and copper plumbing to form highly explosive metal azides. Upon disposal, flush with 
large volumes of water to prevent azide build-up in plumbing. 
3. Minimize microbial contamination of reagents or increase in nonspecific staining may occur. 
4. Wear appropriate Personal Protective Equipment to avoid contact with eyes and skin. 
5. Unused solution should be disposed of according to local, State and Federal regulations. 
Storage 
Store at 2–8 °C. Do not freeze

DAKO抗體是丹麥的著名抗體生產(chǎn)商，提供世界上質量zui穩(wěn)定，zui為經(jīng)典的抗體。其主要產(chǎn)品涉及免疫化學、流式細胞，免疫組織化學，原位雜交，微生物檢驗等。DAKO的不同顯色系統(tǒng)，Envision，LSAB和免疫細胞化學的CAS，GenpointTM和用于分子病理學的PNA=ISH試劑盒，和用于ELISA的AMPAKTM/AmpliQ是其在生物化學研究中的革新產(chǎn)品 。

2012年5月17日，安捷倫科技公司（紐約證交所：A）22億美元收購安捷倫收購丹麥癌癥診斷公司Dako（丹科）。